The Enterprise Value as of December 2025 (TTM) for Anebulo Pharmaceuticals, Inc. (ANEB) is 87.02M

According to Anebulo Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 87.02M. This represents a change of 80.05% compared to the average of 48.33M of the last 4 quarters.

Anebulo Pharmaceuticals, Inc. (ANEB) Historical Enterprise Value (quarterly & annually)

How has ANEB Enterprise Value performed in the past?

The mean historical Enterprise Value of Anebulo Pharmaceuticals, Inc. over the last ten years is 93.75M. The current 87.02M Enterprise Value has changed 9.18% with respect to the historical average. Over the past ten years (40 quarters), ANEB's Enterprise Value was at its highest in in the September 2020 quarter at 168.21M. The Enterprise Value was at its lowest in in the March 2025 quarter at 22.36M.

Anebulo Pharmaceuticals, Inc. (ANEB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Anebulo Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anebulo Pharmaceuticals, Inc. (ANEB) Average Enterprise Value

How has ANEB Enterprise Value performed in the past?

The current Enterprise Value of Anebulo Pharmaceuticals, Inc. (ANEB) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Anebulo Pharmaceuticals, Inc. (ANEB) Enterprise Value vs. Peers

How is ANEB’s Enterprise Value compared to its peers?

Anebulo Pharmaceuticals, Inc.’s Enterprise Value is greater than Tiziana Life Sciences Ltd (-65269000.00), less than Immix Biopharma, Inc. (147.65M), greater than Whitehawk Therapeutics Inc (-24287393.00), less than Zentalis Pharmaceuticals, Inc. (101.24M), greater than Coya Therapeutics, Inc. (-29657635354.00), greater than Pliant Therapeutics, Inc. (16.18M), greater than Clene Inc. (72.09M), greater than MacroGenics, Inc. (44.18M), greater than Estrella Immunopharma, Inc. (71.57M), greater than OKYO Pharma Limited (74.04M),

Build a custom stock screener for Anebulo Pharmaceuticals, Inc. (ANEB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anebulo Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anebulo Pharmaceuticals, Inc. (ANEB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anebulo Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.